{
    "links": "https://www.ycombinator.com/companies/endpoint-health",
    "name": "Endpoint Health",
    "headline": "Precision-first therapies",
    "batch": "W19",
    "description": "Endpoint Health is on a mission to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient\u2019s biology. We built Endpoint Health from the ground up to develop and commercialize therapeutics and therapy-guiding tests, to ensure that every patient receives personalized treatment that will dramatically improve their outcomes. Our vision is a world in which all patients have effective, personalized treatment, because therapies are targeted to the right patient at the right time.",
    "activity_status": "Active",
    "website": "https://endpointhealth.com/",
    "founded_date": 2018.0,
    "team_size": 23.0,
    "location": "Palo Alto",
    "group_partner": null,
    "group_partner_yc": null,
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "location:san-francisco-bay-area",
    "founders": [
        {
            "name": "Diego Rey, Founder/CSO",
            "description": "Diego Rey, born in Bariloche, Argentina and now based in San Francisco, holds a BS (UCSB) in electrical engineering and PhD (Cornell) in biomedical engineering minoring in applied engineering physics and biophysics. He co-founded GeneWEAVE (acquired by Roche) and Endpoint Health (W19) developing rapid bacterial detection and immune disease therapeutics. Diego was the first bio Visiting Partner at YC. He Angel invests and serves on Cornell advisory councils.",
            "linkedin": "https://www.linkedin.com/in/diegorey/"
        },
        {
            "name": "Jason Springs, Founder",
            "description": null,
            "linkedin": "https://www.linkedin.com/in/jasonsprings/"
        },
        {
            "name": "Leonardo Teixeira, Founder",
            "description": null,
            "linkedin": "https://www.linkedin.com/in/leonardomteixeira"
        }
    ],
    "status": true,
    "generated_description": "**Endpoint Health: Innovating Precision Medicine**\n\nFounded in 2018 and based in Palo Alto, Endpoint Health has set out on an ambitious mission: to create precision-first therapies that address critical and chronic immune-driven illnesses. With a team of 23 and backing from Y Combinator's Batch W19, they are pioneering a new approach in the biopharma industry.\n\nAt the core of Endpoint Health\u2019s vision is the belief that every patient deserves personalized treatment. Their mantra, \"patient-first,\" flips the traditional molecule-first drug development model on its head. Instead of creating drugs and then trying to fit them to patients, they aim to tailor treatments based on each patient\u2019s unique biology. This targeted approach has the potential to dramatically improve patient outcomes.\n\nEndpoint Health is actively developing therapies and therapy-guiding tests, all designed to ensure effective treatment reaches the right patient at the right time. Their focus on precision immunology reflects an understanding of the complexity of human biology and the personal nature of immune-mediated diseases. They're also building a robust clinical and data ecosystem to support this precision approach.\n\nIf you're interested in exploring more about their innovative strategies, or to see how they might fit into the broader landscape of biopharma, check out their [website](https://endpointhealth.com/) where they detail their approach, pipeline, and ongoing partnerships. \n\nIn summary, Endpoint Health is not just another biopharmaceutical company; it's a new kind of biopharma that redefines how therapeutic treatments are developed and administered, all with a singular goal in mind: to revolutionize patient care.",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/d136c2a2dbe06f4c5ea13296344f11d0bbe6fff5.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAKBB576US%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T191314Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJHMEUCIFRjVxB%2FHxIJHUHkMazoRi02jYmaJVJGr3K7C9j9jiflAiEA6iszI4%2Fpn8hDzk7aMP6LlnqynbPgCG20CpdZqslTFdsq7gMI3P%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FARAAGgwwMDYyMDE4MTEwNzIiDNVC6v4lNMvTlUOjTyrCA7R4NjcD6pWk9Gjux5NdrMhwU67pNo%2F0JVDzkHcTjBsajnWXpXoyD3m%2FssX0rwYmnUDJB9VTgD%2FW2M8cWxeD93WFxLjs25juzzGj1%2BC1Ky9E0oNPwn5jGw%2BjokWylkxcouU18mjUtP8juH4uF9Xfmm%2FMAgvOPsNSAaYBQ%2BdA5Vwom66MCzynAPEJs6Nqxd5FqtgiiWFRhT5L9g%2FvfLTKqpdIg0XPF6s95lLCtwWDHST72Bn9JVH2zZmqjTgO2sao7Rg4M%2BPIRazg8JhbPoWk6xsB2yfG1f%2Bs8AFVxihyUnQj6TUnhrhezs7WYsaTfaaAoTIzhEsLwJDqBQDSptmSlUj%2BQ3KWwrXpJIm0b1uOmaylnrEpn5obECdRc%2FzdEfNt6DNEE5cbUhQo8Gjfd6MWfyV7JHtX7DwsLMssQPKNZ6qWJq2gP1fVHFkz5K0F%2F73p54AKB5gCkyOeRPJHmAzYMdfZpMF%2B8hE4eZU6k7m1EqPLEW2F9HVvcqPFp8T%2BZgbbDLBVWICSdX%2FfJ%2BniwyC72aHLaqjCxHLvJ6WyAawaepaDD9csEvz4DYD9lpHx9hJXqrFDyrT1vAaaBwuoXgulZ6gNmjCmiuO9BjqlATnnhPFnQUT7QmhXwrAFbGCqdgkRFIVCdDrNmasZJtz86frmIpB%2BlwZjavL0FMq46mN9RKFTuRNdMnOtOh1adMI%2BkC%2F%2Bs3m8pwR56JxErG%2B8nIBe7efeu5WiUZbGCsp85oXBCGY%2FoP1uWrJo843L0LVdmjtyXaDurxXSgzfeZo2RDONME7LNkPzuGzA19XefIc9OvA1QFcZr3VIdZe%2BLywfFgDpgwA%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=3a0453a2900ab37b0e0c374d1b3846ae53801a48accff17f2994310be6d7467d",
    "social_links": [
        "https://www.linkedin.com/company/endpoint-health/",
        "https://twitter.com/endpointhealth",
        "https://www.crunchbase.com/organization/endpoint-health-inc"
    ],
    "logo_path": "data/logos\\Endpoint_Health_logo.png"
}